Shares of Sarepta Therapeutics (NASDAQ:SRPT) traded higher in the premarket on Friday after Scotiabank upgraded the biotech to Sector Outperform from Sector Perform, citing a compelling risk-reward ...

Scotiabank raised the firm’s price target on CN (CNI) to C$165 from C$160 and keeps an Outperform rating on the shares. Published first on TheFly ...

A B.C. man was surprised by fraudulent charges on his credit card, totalling almost $20K — and more surprised to learn his ...

In the quarter, Scotiabank set aside $1.4-billion in provisions for credit losses – the funds banks set aside to cover loans ...

Bank of Nova Scotia missed estimates after setting aside more money than expected for bad credit as tariffs hit its Canadian ...

Against the backdrop the bank moved to raise its quarterly dividend on outstanding shares by 4 cents to C$1.10 a share. It also said it would seek regulatory approval to buy back up to 20 million of ...

Canadians are not spending as much as expected because of tariffs imposed by the United States, Bank of Nova Scotia ...

Cautious borrowers and a worsening economic outlook pushed Scotiabank earnings slightly down in the second quarter from last ...

Canadian lender Bank of Nova Scotia reported a fall in second-quarter profit on Tuesday, due to weakness in its Canadian ...

Let’s start with what’s happening right now. Scotiabank recently released its second-quarter earnings for 2025, and there were some mixed results. The bank reported revenue of $8.4 billion ...

Scotiabank’s guaranteed investment certificates (GICs) offer competitive interest rates, flexible terms, and do not charge monthly fees, but may have an early withdrawal penalty. Depending on ...

Scotiabank’s mortgage growth stalled in Q2, with average balances flat from the previous quarter and originations slowing ...